Nephrology Doctors in Clinton Twp, MI - Medicare Status, Address, Contact

3 Nephrology doctors found. Showing 1 - 3

Dr. Joseph W Kaiser, D.O.
Internal Medicine - Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 15520 19 Mile Rd, Ste 480, Clinton Twp, MI 48038
Phone: 586-228-1010 Fax: 586-228-8570

Omokayode A. Osobamiro, M.D.
Internal Medicine - Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 16151 19 Mile Rd Ste 302, Clinton Twp, MI 48038
Phone: 586-228-7433

Dr. Craig Newton Norris, DO
Internal Medicine - Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 15520 19 Mile Rd, Ste 480, Clinton Twp, MI 48038
Phone: 586-228-1010 Fax: 586-228-8570

News Archive

Local leaders call on state lawmakers to enact new legislation to preserve health care safety net

Citing the devastating impact that pending Medi-Cal payment cuts would have on the Valley's most vulnerable patients, Assemblymember Henry T. Perea (D-Fresno) joined with local hospital leaders today to call on state lawmakers to enact new legislation that would preserve the state's health care safety net.

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.

New system for targeted cancer radiation therapy using gold nanoparticles

Scientists from the Department of Nuclear Medicine and Tracer Kinetics at Osaka University developed a novel system for targeted cancer radiation therapy that uses gold nanoparticles labeled with astatine-211.

Investigational Insomnia Medicine from Merck improved patients' ability to fall and stay asleep according to new phase III Data

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.

New initiative launched to support goals of Human Cell Atlas

Uri Laserson, PhD, Assistant Professor in the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai, and collaborators have been awarded one of 85 grants announced today from the Chan Zuckerberg Initiative DAF (CZI), an advised fund of Silicon Valley Community Foundation.

Nephrology Doctors in Clinton Twp, MI Accepting Medicare